Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
View/ Open
Date
2013-04-01ICR Author
Author
Michailidou, K
Hall, P
Gonzalez-Neira, A
Ghoussaini, M
Dennis, J
Milne, RL
Schmidt, MK
Chang-Claude, J
Bojesen, SE
Bolla, MK
Wang, Q
Dicks, E
Lee, A
Turnbull, C
Rahman, N
Breast and Ovarian Cancer Susceptibility Collaboration,
Fletcher, O
Peto, J
Gibson, L
Dos Santos Silva, I
Nevanlinna, H
Muranen, TA
Aittomäki, K
Blomqvist, C
Czene, K
Irwanto, A
Liu, J
Waisfisz, Q
Meijers-Heijboer, H
Adank, M
Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON),
van der Luijt, RB
Hein, R
Dahmen, N
Beckman, L
Meindl, A
Schmutzler, RK
Müller-Myhsok, B
Lichtner, P
Hopper, JL
Southey, MC
Makalic, E
Schmidt, DF
Uitterlinden, AG
Hofman, A
Hunter, DJ
Chanock, SJ
Vincent, D
Bacot, F
Tessier, DC
Canisius, S
Wessels, LFA
Haiman, CA
Shah, M
Luben, R
Brown, J
Luccarini, C
Schoof, N
Humphreys, K
Li, J
Nordestgaard, BG
Nielsen, SF
Flyger, H
Couch, FJ
Wang, X
Vachon, C
Stevens, KN
Lambrechts, D
Moisse, M
Paridaens, R
Christiaens, M-R
Rudolph, A
Nickels, S
Flesch-Janys, D
Johnson, N
Aitken, Z
Aaltonen, K
Heikkinen, T
Broeks, A
Veer, LJV
van der Schoot, CE
Guénel, P
Truong, T
Laurent-Puig, P
Menegaux, F
Marme, F
Schneeweiss, A
Sohn, C
Burwinkel, B
Zamora, MP
Perez, JIA
Pita, G
Alonso, MR
Cox, A
Brock, IW
Cross, SS
Reed, MWR
Sawyer, EJ
Tomlinson, I
Kerin, MJ
Miller, N
Henderson, BE
Schumacher, F
Le Marchand, L
Andrulis, IL
Knight, JA
Glendon, G
Mulligan, AM
kConFab Investigators,
Australian Ovarian Cancer Study Group,
Lindblom, A
Margolin, S
Hooning, MJ
Hollestelle, A
van den Ouweland, AMW
Jager, A
Bui, QM
Stone, J
Dite, GS
Apicella, C
Tsimiklis, H
Giles, GG
Severi, G
Baglietto, L
Fasching, PA
Haeberle, L
Ekici, AB
Beckmann, MW
Brenner, H
Müller, H
Arndt, V
Stegmaier, C
Swerdlow, A
Ashworth, A
Orr, N
Jones, M
Figueroa, J
Lissowska, J
Brinton, L
Goldberg, MS
Labrèche, F
Dumont, M
Winqvist, R
Pylkäs, K
Jukkola-Vuorinen, A
Grip, M
Brauch, H
Hamann, U
Brüning, T
GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network,
Radice, P
Peterlongo, P
Manoukian, S
Bonanni, B
Devilee, P
Tollenaar, RAEM
Seynaeve, C
van Asperen, CJ
Jakubowska, A
Lubinski, J
Jaworska, K
Durda, K
Mannermaa, A
Kataja, V
Kosma, V-M
Hartikainen, JM
Bogdanova, NV
Antonenkova, NN
Dörk, T
Kristensen, VN
Anton-Culver, H
Slager, S
Toland, AE
Edge, S
Fostira, F
Kang, D
Yoo, K-Y
Noh, D-Y
Matsuo, K
Ito, H
Iwata, H
Sueta, A
Wu, AH
Tseng, C-C
Van Den Berg, D
Stram, DO
Shu, X-O
Lu, W
Gao, Y-T
Cai, H
Teo, SH
Yip, CH
Phuah, SY
Cornes, BK
Hartman, M
Miao, H
Lim, WY
Sng, J-H
Muir, K
Lophatananon, A
Stewart-Brown, S
Siriwanarangsan, P
Shen, C-Y
Hsiung, C-N
Wu, P-E
Ding, S-L
Sangrajrang, S
Gaborieau, V
Brennan, P
McKay, J
Blot, WJ
Signorello, LB
Cai, Q
Zheng, W
Deming-Halverson, S
Shrubsole, M
Long, J
Simard, J
Garcia-Closas, M
Pharoah, PDP
Chenevix-Trench, G
Dunning, AM
Benitez, J
Easton, DF
Type
Journal Article
Metadata
Show full item recordAbstract
Breast cancer is the most common cancer among women. Common variants at 27 loci have been identified as associated with susceptibility to breast cancer, and these account for ∼9% of the familial risk of the disease. We report here a meta-analysis of 9 genome-wide association studies, including 10,052 breast cancer cases and 12,575 controls of European ancestry, from which we selected 29,807 SNPs for further genotyping. These SNPs were genotyped in 45,290 cases and 41,880 controls of European ancestry from 41 studies in the Breast Cancer Association Consortium (BCAC). The SNPs were genotyped as part of a collaborative genotyping experiment involving four consortia (Collaborative Oncological Gene-environment Study, COGS) and used a custom Illumina iSelect genotyping array, iCOGS, comprising more than 200,000 SNPs. We identified SNPs at 41 new breast cancer susceptibility loci at genome-wide significance (P < 5 × 10(-8)). Further analyses suggest that more than 1,000 additional loci are involved in breast cancer susceptibility.
Collections
Subject
Breast and Ovarian Cancer Susceptibility Collaboration
Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
kConFab Investigators
Australian Ovarian Cancer Study Group
GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network
Humans
Breast Neoplasms
Genetic Predisposition to Disease
Risk Factors
Case-Control Studies
Cooperative Behavior
Genotype
Polymorphism, Single Nucleotide
Female
Meta-Analysis as Topic
Genome-Wide Association Study
Genetic Loci
Gene-Environment Interaction
Research team
Complex Trait Genetics
Functional Genetic Epidemiology
Molecular Epidemiology
Predisposition & Translation Genetics
Aetiological Epidemiology
Genetic Susceptibility
Gene Function
Language
eng
Date accepted
2013-01-30
License start date
2013-04
Citation
Nature genetics, 2013, 45 (4), pp. 353 - 361e2
Publisher
NATURE PUBLISHING GROUP
Related items
Showing items related by title, author, creator and subject.
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2,; Hollestelle, A; van der Baan, FH; Berchuck, A; Johnatty, SE; et al. (ACADEMIC PRESS INC ELSEVIER SCIENCE, 2016-05-01)OBJECTIVE: Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer ... -
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
Fehringer, G; Kraft, P; Pharoah, PD; Eeles, RA; Chatterjee, N; et al. (AMER ASSOC CANCER RESEARCH, 2016-09-01)Identifying genetic variants with pleiotropic associations can uncover common pathways influencing multiple cancers. We took a two-stage approach to conduct genome-wide association studies for lung, ovary, breast, prostate, ... -
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Lawrenson, K; Kar, S; McCue, K; Kuchenbaeker, K; Michailidou, K; et al. (NATURE PORTFOLIO, 2016-09-07)A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify ...